Abernathy EC, Hruban RH, Baumgartner WA, et al. The two forms of bronchiolitis
obliterans in heart-lung transplant recipients. Hum Pathol 1991; 22(11): 1102-1110.
Al-Dossari GA, Jessurun J, Bolman M, et al.
Pathogenesis of obliterative bronchiolitis. Possible roles of platelet-derived
growth factor and basic fibroblast growth factor. Transplantation 1995; 15(1):143-145.
Anderson WR, Coulon TF, Kiesel TM, et al. Morphologic characteristics of
rejection of the baboon lung allograft. Primates Med 1972; 7:81.
Bando K, Paradis IL, Keenan RJ, et al. Comparison of outcomes after single and bilateral lung transplantation for obstructive lung
disease. J Heart Lung Transplant 1995; 14(4):692-698.
Barbera JA, Hayashi S, Hergele RG, et al. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis
1992; 145(4 Pt 1):940-946.
Barnes BA, Flax MH, Burke JF, et al. Experimental pulmonary homografts in the
dog. I. Morphological studies. Transplantation 1963; 1:351.
Becroft DM. Bronchiolitis obliterans, bronchiectasis, and other sequelae of
adenovirus type 21 infection in young children.
J Clin Pathol 1971; 24(1):72-82.
Berg LC, Copenhaer CM, Morrison VA, et al. B-cell lymphoproliferative
disorders
in solid organ transplant patients: Detection of Epstein-Barr virus by in situ
hybridization. Hum Pathol 1992; 23(2):159-163.
Brooks RG, Hofflin JM, Jamieson SW, et al. Infectious complications in
heart-lung transplant recipients. Am J Med 1985; 79(4): 412-422.
Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative
bronchiolitis and other late lung sequelae in human heart-lung transplantation.
Chest 1984; 86(6): 824-829.
Burke CM, Glanville AR, Theodore J, et al. Lung immunogenicity, rejection, and obliterative broncholitis. Chest 1987; 92(3):547-549.
Burke CM, Yousem SA, Corris PA. Heart-lung transplantation. Diseases of the Bronchioles, edited by Gary R. Epler. Raven Press, Ltd. 1994.
Byers JM 3d, Sabanayagam P, Baker RR, et al. Pathologic changes in baboon lung
allografts. Comparison of two immunosuppression regimes.
Ann Surg 1973; 178(6):754-760.
Clelland CA, Higenbottam TW, Monk JA, et al. Bronchoalveolar lavage lymphocytes
in relation to transbronchial lung biopsy in heart-lung transplants. Transplant
Proc 1990; 22(4):1479.
Clelland C, Higenbottam T, Otulana B, et al. Histologic prognostic indicators
for the lung allografts of heart-lung transplants. J Heart Transplant 1990; 9(3 Pt 1):177-185.
Clelland C, Higenbottam T, Stewart S, et al. Bronchoalveolar lavage and
transbronchial lung biopsy during acute rejection and infection in heart-lung
transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am Rev Respir Dis 1993; 147(6 Pt 1):1386-1392.
de Blic J, Peuchmaur M, Carnot F, et al. Rejection in lung transplantation -
an immunohistochemical study of transbronchial biopsies. Transplantation 1992;
54(4):639-644.
De Hoyos A, Chamberlain D, Schvartzman R, et al. Prospective assessment of a standardized pathologic grading system for
acute rejection in lung transplantation. Chest 1993; 103(6):1813-1818.
Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in the
acquired immunodeficiency syndrome. N Engl J Med 1991; 324(10): 654-662.
Dummer JS, White LT, Ho M, et al. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis
1985; 152(6): 1182-1191.
Fournier M, Lebargy F, Le Roy Ladurie F, et al. Intraepithelial T-lymphocyte
subsets in the airways of normal subjects and of patients with chronic
bronchitis. Am Rev Respir Dis 1989; 140(3): 737-742.
Frizzera G, Hanot DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell
hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981;
41(11 Pt 1):4262-4279.
Frost AE, Keller CA, Noon GP, et al. Outcome of the native lung after single lung transplant. Multiorgan Transplant Group. Chest 1995;
107(4):981-984.
Glanville AR, Baldwin JC, Burke CM, et al. Obliterative bronchiolitis after
heart-lung transplantation: Apparent arrest by augmented immunosuppression. Ann
Intern Med 1987; 107(3): 300-304.
Goldman M, Gerard C, Abramowicz D, et al. Induction of interleukin-6 and
interleukin-10 by the OKT3 monoclonal antibody: Possible relevance to posttransplant
lymphroliferative disorders. Clin Transplant 1992; 6: 265-268.
Gray J, Wreghitt TG, Pavel P, et al. Epstein -Barr virus infection in heart and heart-lung transplant
recipients: incidence and clinical impact. J Heart Lung Transplant 1995;
14(4):640-646.
Griffith BP, Hardesty RL, Trento A, et al. Heart-lung transplantation: lessons
learned and future hopes. Ann Thorac Surg 1987; 43(1):6-16.
Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence of
Pneumocystis carinii infection after lung-heart transplantation. Implications for
lung defense and allograft survival. Am Rev Respir Dis 1988; 137(6):1268-1274.
Harjula AL, Baldwin JC, Glanville AR, et al. Human leukocyte antigen
compatibility in heart-lung transplantation. J Heart Transplant 1987; 6(3):162-166.
Hasegawa S, Ockner DM, Ritter JH, et al. Expression of class II major
histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic
pulmonary transplant rejection. Arch Pathol Lab Med 1995; 119:432-439.
Haverich A, Dawkins KD, Baldwin JC, et al. Long-term cardiac and pulmonary
histology in primates following combined heart and lung transplantation.
Transplantation 1985; 39(4):356-360.
Higenbottam TW, Penketh AR, Stewart S, et al. The diagnosis of lung rejection
and opportunistic lung infection of heart-lung transplant patients using
transbronchial lung biopsy. Transplantation 1988; 46: 532.
Higenbottam T, Stewart S, Penketh A, et al. Transbronchial lung biopsy for
the diagnosis of rejection in heart-lung transplant patients. Transplantation
1988; 46(4):532-539.
Higenbottam TW, Stewart S. Transbronchial lung biopsy in the diagnosis of
rejection of the tranplanted lung. In: Wallwork JL, ed. Heart and Lung
Transplantation. Philadelphia: WB Saunders, 1989.
Holland VA, Cale PT, Windsor NT, et al. Lymphocyte subset populations in
bronchiolitis obliterans after heart-lung transplantation. Transplantation 1990;
50(6): 955-959.
Hruban RH, Beschorner WE, Baumgartner WA, et al. Diagnosis of lung allograft
rejection by bronchial intraepithelial Leu-7 positive T lymphocytes. J Thorac
Cariovasc Surg 1988; 96(6): 939-946.
Hruban RH, Beschorner WE, Baumgartner WA, et al. Depletion of
bronchus-associated lymphoid tissue associated with lung allograft rejection. Am J Pathol
1988; 132(1): 6-11.
Humbert M, Deveregne O, Cerrina J, et al. Activation of macrophages and
cytotoxic cells during cytomegalovirus pneumonia complicating lung transplantations.
Am Rev Respir Dis 1992; 145(5): 1178-1184.
Hunninghake GW, Kawanami O, Ferrans VJ, et al. Characterization of the
inflammatory and immune effector cells in the lung parenchyma of patients with
interstitial lung disease. Am Rev Respir Dis 1981; 123(4 Pt 1):407-412.
Hunt JB, Stewart S, Cary N, et al. Evaluation of the International Society for
Heart Transplantation grading of pulmonary rejection in 100 consecutive biopsies.
Transplant Int 5 1992; 5:249.
Hutter JA, Despins P, Higenbottam T, et al. Heart-lung transplantation: Better
use of resources. Am J Med 1988 85(1):4-11.
Hutter JA, Stewart S, Higenbottam TW, et al. The characteristic histological
changes associated with rejection in heart-lung transplant recipients. Transplant
Proc 1989; 21(1 Pt 1):435-436.
Hutter JA, Scott J, Wreghitt T, et al. The importance of cytomegalovirus in
heart-lung transplant recipients. Chest 1989; 95(3): 627-631.
Katzenstein AL, Askin FB. Surgical Pathology of Non Neoplastic Lung Disease.
Philadelphia: WB Saunders, 1982; 349.
Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serologic status and
postoperative infection correlated with risk of developing chronic rejection after
pulmonary transplantation. Transplantation 1991; 51(2):433-438.
Keller CA, Cagle PT, Brown RW, et al. Bronchiolitis obliterans in
recipients of single, double, and heart-lung transplantation. Chest 1995;
107(4):973-980.
Kondo Y, Cockrell JV, Kuwahara O, et al. Histopathology of one-stage bilateral lung
allografts. Ann Surg 1974; 180(5):753-759.
Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after
lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144(3 Pt 1):552-556.
Lower RR, Stofer RC, Hurley EJ, et al. Complete homograft replacement of the
heart and both lungs. Surgery 1961; 50:842.
Marck KW, Prop J, Wildevuur CR, et al. Lung transplantation in the rat:
Histopathology of left lung iso- and allografts. J Heart Transplant 1985; 4(2):263-266.
Maurer JR, Tullis DE, Grossman RF, et al. Infectious complications following
isolated lung transplantation. Chest 1992; 101(4):1056-1059.
Millard PR, Heryet AR. Observations favouring Pneumocystis carinii pneumonia as
a primary infection: A monoclonal antibody study on paraffin sections. J Pathol
1988; 154(4):365-370.
Millet B, Higenbottam TW, Flower CD, et al. The radiographic appearances of
infection and acute rejection of the lung after heart-lung transplantation.
Am Rev Respir Dis 1989; 140(1):62-67.
Milne DS, Gascoigne AD, Ashcroft T, et al. Organizing pneumonia following
pulmonary transplantation and the development of obliterative bronchiolitis.
Transplantation 1994; 57(12):1757-1762.
Milne DS, Gascoigne AD, Wilkes J, et al. MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients.
Transplantation 1994; 57(12):1762-1766.
Myerson D, Hackman RC, Nelson JA, et al. Widespread presence of histologically
occult cytomegalovirus. Hum Pathol 1984; 15(5): 430-439.
Nalesnik MA, Locker J, Jaffe R, et al. Experience with posttransplant
lymphoproliferative disorders in solid organ transplant recipients. Clin
Transplantation 1992; 6: 249-252.
Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant
lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone
immunosuppression. Am J Pathol 1988; 133(1):173-192.
Nathan SD, Ross DJ, Belman MJ, et al.
Bronchiolitis obliterans in single-lung transplant recipients. Chest 1995;
107(4):967-972.
Nibbering PH, van der Heide A, van Furth R. Macrophages in broncho-alveolar
lavage fluid are not representative of macrophages in granulomas of the lungs of BCG-infected mice. J Pathol 1989; 157(3): 253-261.
Niedobitek G, Finn T, Herbst H, et al. Detection of cytomegalovirus by
in situ
hybridization and immunohistochemistry using new monoclonal antibody CCH2: a comparison of
methods. J Clin Pathol 1988; 41(9):1005-1009.
Norin AJ, Emeson EE, Kamholz SL, et al. Cyclosporine A as the initial
immunosuppressive agent for canine lung transplantation. Short- and long-term
assessment of rejection phenomena. Transplantation 1982; 34(6):372-375.
Prop J, Nieuwenhuis P, Wildevuur CR. Lung allograft rejection in the rat. I.
accelerated rejection caused by graft lymphocytes. Transplantation.
1985; 40(1):25-30.
Prop J, Tazelaar HD, Billingham ME. Rejection of combined heart-lung
transplants in rats. Function and pathology. Am J Pathol 1987; 127(1):97-105.
Prop J, Wildevuur CR, Niewenhuis P. Lung allograft rejection in the rat. II.
Specific immunological properties of lung grafts.
Transplantation 1985; 40(2):126-131.
Prop J, Wildevuur CR, Nieuwenhuis P. Lung allograft rejection in the rat.
III.
Corresponding morphological rejection phases in various rat strain combinations.
Transplantation 1985; 40(2):132-136.
Reinsmoen NL, Bolman RM, Savik K, et al. Differentiation of class I- and class
II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from
lung transplant recipients. Transplantation 1992; 53(1):181-189.
Reitz BA, Burton NA, Jamieson SW, et al. Heart and lung transplantation:
Autotransplantation and allotransplantation in primates with extended survival.
J Thorac Cardiovasc Surg 1980; 80(3):360-372.
Randhawa PS, Yousem SA, Paradis IL, et al. The clinical spectrum, pathology,
and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders
in heart-lung transplant recipients. Am J Clin Pathol 1989; 92(2): 177-185.
Romaniuk A, Prop J, Petersen AH, et al. Expression of class II major
histocompatibility complex antigens by bronchial epithelium in rat lung allografts.
Transplantation 1987; 44(2): 209-214.
Rosendale B, Yousem SA. Discrimination of Epstein-Barr virus-related
posttransplant lymphoproliferations from acute rejection in lung allograft
recipients. Arch Pathol Lab Med 1995; 119(5):418-423.
Scott JP, Higenbottam TW, Sharples L, et al. Risk factors for obliterative
bronchiolitis in heart-lung transplant recipients. Transplantation 1991;
51(4): 813-817.
Shennib H, Nguyen D, Guttmann RD, et al. Phenotypic expression of
bronchoalveolar lavage cells in lung rejection and infection. Ann Thorac Surg
1991; 51(4): 630-635.
Stewart S, Higenbottam TW, Hutter JA, et al. Histopathology of transbronchial
biopsies in heart-lung transplantation. Transplant Proc 1988; 20(1):764-766.
Su IJ, Lin KH, Chen CJ, et al. Epstein-Barr virus-associated
peripheral T-cell lymphoma of activated CD8 phenotype. Cancer 1990; 66(12): 2557-2562.
Sundaresan S, Alevy YG, Steward N, et al. Cytokine gene transcripts for tumor necrosis factor-alpha,
interleukin-2, and interferon-gamma in human pulmonary allografts. J Heart Lung
Transplant 1995; 14(3):512-518.
Smyth RL, Scott JP, Borysiewicz LK, et al. Cytomegalovirus infection in
heart-lung transplant recipients: risk factors, clinical associations, and response to treatment.
J Infect Dis 1991; 164(6): 1045-1050.
Smyth RL, Higenbottam TW, Scott JP, et al. Herpes simplex virus infection in
heart-lung transplant recipients. Transplantation 1990; 49(4): 735-739.
Swerdlow SH. Post-transplant lymphoproliferative disorders: A morphologic,
phenotypic and genotypic spectrum of disease. Histopathology 1992; 20(5):373-385.
Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations
of pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas.
Am J Surg Pathol 1990; 14(7): 615-625.
Trulock EP, Bolamn RM, Genton R. Pulmonary disease caused by mycobacterium
chelonae in a heart-lung transplant recipient with obliterative bronchiolitis.
Am Rev Respir Dis 1989; 140(3):802-805.
Trulock EP, Ettinger NA, Brunt EM, et al.
The role of
transbronchial lung biopsy in the treatment of lung transplant recipients. An
analysis of 200 consecutive procedures. Chest 1992; 102(4):1049-1054.
Veal CF Jr, Carr MB, Briggs DD Jr. Diffuse pneumonia and acute respiratory failure
due to infectious mononucleosis in a middle-aged adult. Am Rev Respir Dis
1990; 141(2):502-504.
Veith FJ, Hagstrom JWC, Anderson WR, et al. Alveolar manifestations of
rejection: An important cause of the poor results with human lung transplantation.
Ann Surg 1972; 175(3):336-348.
Veith FJ, Koerner SK, Siegelman SS, et al. Diagnosis and reversal of rejection
in experimental and clinical lung allografts.
Ann Thorac Surg 1973; 16(2):172-183.
Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus
status is the primary risk factor for posttransplantation lymphoproliferative
disorder in adult heart, lung, and other solid organ transplantations. J Heart
Lung Transplant 1995; 14(2):214-221.
Walts AE, Marchevsky AM, Morgan M. Pulmonary cytology in lung transplant
recipients: recent trends in laboratory utilization. Diagn Cytopathol 1991; 7(4):353-358.
Weber WR, Askin FB, Dehner LP. Lung biopsy in Pneumocystis carinii pneumonia:
A histopathologic study of typical and atypical features. Am J Clin Pathol
1977; 67(1):11-19.
Weiss LM, Movahed LA, Berry GJ, et al. In situ hybridization studies for viral
nucleic acids in heart and lung allograft biopsies. Am J Clin Pathol
1990; 93(5): 675-679.
Winter JB, Clelland C, Gouw AS, et al. Distinct phenotypes of infiltrating
cells during acute and chronic lung rejection in human heart-lung transplants.
Transplantation 1995; 59(1):63-69.
Winter JB, Groen M, Welling S, et al. Inadequate antibody response against
respiratory viral infection in long-surviving rat lung allografts.
Transplantation 1995; 59(11):1583-1589.
Wyatt SE, Nunn P, Hows JM, et al. Airways obstruction associated with graft versus host
disease after bone marrow transplantation. Thorax 1984; 39(12): 887-894.
Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the
standardization of nomenclature in the diagnosis of heart and lung rejection: Lung
Rejection Study Group. J Heart Transplant 1990; 9(6):593-601.
Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in
long-term human heart-lung transplantation. Hum Pathol. 1985; 16(9):911-923.
Yousem SA, Paradis IL, Dauber JH, et al. Efficacy of transbronchial lung biopsy
in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 1989; 47(5):893-895.
Yousem SA, Dauber JA, Keenan R, et al. Does histologic acute rejection in lung
allografts predict the development of bronchiolitis obliterans? Transplantation
1991; 52(2): 306-309.
Yousem SA, Duncan SR, Griffith BP. Interstitial and airspace granulation
tissue
reactions in lung transplant recipients. Am J Surg Pathol. 1992; 16(9):877-884.
Yousem SA, Paradis IL, Dauber JH, et al. Pulmonary arteriosclerosis in
long-term human heart-lung transplant recipients.
Transplantation 1989; 47(3):564-569.
Yousem SA, Randhawa P, Locker J, et al. Posttransplant lymphoproliferative
disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol. 1989; 20(4):361-369.
Yousem SA, Tazelaar HD. Combined heart-lung transplantation. In: Sale GE, ed.
The Pathology of Organ Transplantation. Boston: Butterworths, 1990: 153.
Zeevi A, Fung JJ, Paradis IL, et al. Lymphocytes of bronchoalveolar lavages
from
heart-lung transplant recipients. J Heart Transplant 1985; 4(4):417-421.
Please mail comments, corrections or suggestions to the
TPIS administration at the UPMC.
